These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2465284)

  • 1. Vaccination against experimental autoimmune disease using autoimmune T-lymphocytes.
    Cohen IR
    Isr J Med Sci; 1988 Dec; 24(12):734-6. PubMed ID: 2465284
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunospecific therapy of central nervous system autoaggression with an antigen-specific T cell line.
    Wekerle H
    Prog Clin Biol Res; 1984; 146():435-41. PubMed ID: 6201913
    [No Abstract]   [Full Text] [Related]  

  • 3. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis.
    Vandenbark AA; Gill T; Offner H
    J Immunol; 1985 Jul; 135(1):223-8. PubMed ID: 2582032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines.
    Ben-Nun A; Cohen IR
    J Immunol; 1982 Mar; 128(3):1450-7. PubMed ID: 6173439
    [No Abstract]   [Full Text] [Related]  

  • 5. T lymphocyte clones and experimental autoimmune diseases.
    Cohen IR
    Behring Inst Mitt; 1985 Aug; (77):88-92. PubMed ID: 2417586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D.
    Matsumoto Y; Fujiwara M
    Cell Immunol; 1993 Jul; 149(2):268-78. PubMed ID: 7687198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymphocyte lines directed against diverse antigenic determinants of myelin basic protein. Vaccination is determinant specific.
    Holoshitz J; Frenkel A; Ben-Nun A; Cohen IR
    J Immunol; 1983 Dec; 131(6):2810-3. PubMed ID: 6196400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with a synthetic T-cell receptor V-region peptide: immunomodulation or vaccination.
    Kaneko H; Iizuka K; Kokai Y; Fujimoto JI; Hirasawa A; Tsujimoto G; Koike H; Torres-Nagel N; Hunig T; Kimura H
    Transplant Proc; 1995 Apr; 27(2):1539-42. PubMed ID: 7536968
    [No Abstract]   [Full Text] [Related]  

  • 9. An assessment of actively induced and adoptively transferred experimental allergic encephalomyelitis in the nude rat.
    Hinrichs DJ; Wegmann KW; Humphres RC
    Prog Clin Biol Res; 1984; 146():307-11. PubMed ID: 6201904
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro selection of permanent T lymphocyte lines with receptors for myelin basic protein (MBP).
    Schluesener HJ; Wekerle H
    Prog Clin Biol Res; 1984; 146():285-90. PubMed ID: 6201900
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of microglia in autoimmune encephalomyelitis.
    Matsumoto Y
    Neuropathol Appl Neurobiol; 1994 Apr; 20(2):196-8. PubMed ID: 7521021
    [No Abstract]   [Full Text] [Related]  

  • 12. Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats.
    Malotky MK; Pope L; Miller SD
    J Immunol; 1994 Jul; 153(2):841-51. PubMed ID: 7517425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of T lymphocytes in the pathogenesis of experimental autoimmune encephalomyelitis.
    Lennon VA; Byrd WJ
    Eur J Immunol; 1973 Apr; 3(4):243-5. PubMed ID: 4123774
    [No Abstract]   [Full Text] [Related]  

  • 15. Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis (1,2).
    Paterson PY; Day ED
    Clin Immunol Rev; 1981-1982; 1(4):581-697. PubMed ID: 6188568
    [No Abstract]   [Full Text] [Related]  

  • 16. Encephalitogenic epitopes of myelin basic protein.
    Fritz RB; McFarlin DE
    Chem Immunol; 1989; 46():101-25. PubMed ID: 2482036
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats.
    Stepaniak JA; Gould KE; Sun D; Swanborg RH
    J Immunol; 1995 Sep; 155(5):2762-9. PubMed ID: 7544385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
    Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M
    J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis.
    Burrows GG; Bebo BF; Adlard KL; Vandenbark AA; Offner H
    J Immunol; 1998 Dec; 161(11):5987-96. PubMed ID: 9834080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
    Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
    Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.